Trial Profile
Effect of Vasopressin Antagonism on Renal Sodium and Water Handling and Circulation During Inhibition of the Nitric Oxide System in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Cardiac oedema
- Focus Biomarker; Pharmacodynamics
- Acronyms TORA
- 19 Jul 2012 New trial record